0 Avaliações

ID

16793

Descrição

Arsenic Trioxide in Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma; ODM derived from: https://clinicaltrials.gov/show/NCT00193518

Link

https://clinicaltrials.gov/show/NCT00193518

Palavras-chave

  1. 07/08/2016 07/08/2016 -
Transferido a

7 de agosto de 2016

DOI

Para um pedido faça login.

Licença

Creative Commons BY 4.0

Comentários do modelo :

Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.

Comentários do grupo de itens para :

Comentários do item para :


    Sem comentários

    Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.

    Eligibility Chronic Lymphocytic Leukemia NCT00193518

    Eligibility Chronic Lymphocytic Leukemia NCT00193518

    Inclusion Criteria
    Descrição

    Inclusion Criteria

    Alias
    UMLS CUI
    C1512693
    to be included in this study, you must meet the following criteria:
    Descrição

    Inculsion criteria

    Tipo de dados

    boolean

    Alias
    UMLS CUI [1]
    C1512693
    histologically proven b-cell cll/sll.
    Descrição

    b-cell cll/sll

    Tipo de dados

    boolean

    Alias
    UMLS CUI [1]
    C1302547
    must have had a minimum of 1 and a maximum of 3 previous systemic regimens
    Descrição

    previous therapy

    Tipo de dados

    boolean

    Alias
    UMLS CUI [1]
    C1514463
    must have progressive cll/sll
    Descrição

    progressive cll/sll

    Tipo de dados

    boolean

    Alias
    UMLS CUI [1,1]
    C1302547
    UMLS CUI [1,2]
    C1335499
    measurable or evaluable disease
    Descrição

    measurable or evaluable disease

    Tipo de dados

    boolean

    Alias
    UMLS CUI [1]
    C1513041
    UMLS CUI [2]
    C1516986
    ecog performance status 0, 1, or 2
    Descrição

    ecog performance status

    Tipo de dados

    boolean

    Alias
    UMLS CUI [1]
    C1520224
    age > 18 years.
    Descrição

    age

    Tipo de dados

    boolean

    Alias
    UMLS CUI [1]
    C0001779
    patients with cytopenias caused by bone marrow involvement are eligible
    Descrição

    cytopenia, bone marrow involvement

    Tipo de dados

    boolean

    Alias
    UMLS CUI [1]
    C0010828
    UMLS CUI [2]
    C1517677
    all patients must give written informed consent prior to entering this study.
    Descrição

    informed consent

    Tipo de dados

    boolean

    Alias
    UMLS CUI [1]
    C0021430
    Exclusion Criteria
    Descrição

    Exclusion Criteria

    Alias
    UMLS CUI
    C0680251
    you cannot participate in this study if any of the following apply to you:
    Descrição

    exclusion criteria

    Tipo de dados

    boolean

    Alias
    UMLS CUI [1]
    C0680251
    unstable active infection on the basis of neutropenia
    Descrição

    unstable active infection on the basis of neutropenia

    Tipo de dados

    boolean

    Alias
    UMLS CUI [1,1]
    C0009450
    UMLS CUI [1,2]
    C0205177
    UMLS CUI [1,3]
    C0443343
    UMLS CUI [2]
    C0027947
    previous severe opportunistic infections
    Descrição

    severe opportunistic infections

    Tipo de dados

    boolean

    Alias
    UMLS CUI [1,1]
    C0029118
    UMLS CUI [1,2]
    C0205082
    severe immune mediated anemia or thrombocytopenia
    Descrição

    severe immune mediated anemia or thrombocytopenia

    Tipo de dados

    boolean

    Alias
    UMLS CUI [1,1]
    C0002880
    UMLS CUI [1,2]
    C0205082
    UMLS CUI [2,1]
    C0242584
    UMLS CUI [2,2]
    C0205082
    serious underlying medical conditions
    Descrição

    comorbidity

    Tipo de dados

    boolean

    Alias
    UMLS CUI [1]
    C0009488
    brain metastases or meningeal involvement
    Descrição

    brain metastases or meningeal involvement

    Tipo de dados

    boolean

    Alias
    UMLS CUI [1]
    C0220650
    UMLS CUI [2]
    C1704231
    history of other neoplasms
    Descrição

    other neoplasms

    Tipo de dados

    boolean

    Alias
    UMLS CUI [1,1]
    C0006826
    UMLS CUI [1,2]
    C0205394
    significant underlying heart dysfunction
    Descrição

    cardiac dysfunction

    Tipo de dados

    boolean

    Alias
    UMLS CUI [1]
    C3277906
    women who are pregnant or
    Descrição

    Pregnancy

    Tipo de dados

    boolean

    Alias
    UMLS CUI [1]
    C0032961
    please note: there are additional inclusion/exclusion criteria. the study center will determine if you meet all of the criteria. if you do not qualify for the trial, study personnel will explain the reasons. if you do qualify, study personnel will explain the trial in detail and answer any questions you may have.
    Descrição

    eligibility criteria

    Tipo de dados

    boolean

    Alias
    UMLS CUI [1]
    C1516637

    Similar models

    Eligibility Chronic Lymphocytic Leukemia NCT00193518

    Name
    Tipo
    Description | Question | Decode (Coded Value)
    Tipo de dados
    Alias
    Item Group
    C1512693 (UMLS CUI)
    Inculsion criteria
    Item
    to be included in this study, you must meet the following criteria:
    boolean
    C1512693 (UMLS CUI [1])
    b-cell cll/sll
    Item
    histologically proven b-cell cll/sll.
    boolean
    C1302547 (UMLS CUI [1])
    previous therapy
    Item
    must have had a minimum of 1 and a maximum of 3 previous systemic regimens
    boolean
    C1514463 (UMLS CUI [1])
    progressive cll/sll
    Item
    must have progressive cll/sll
    boolean
    C1302547 (UMLS CUI [1,1])
    C1335499 (UMLS CUI [1,2])
    measurable or evaluable disease
    Item
    measurable or evaluable disease
    boolean
    C1513041 (UMLS CUI [1])
    C1516986 (UMLS CUI [2])
    ecog performance status
    Item
    ecog performance status 0, 1, or 2
    boolean
    C1520224 (UMLS CUI [1])
    age
    Item
    age > 18 years.
    boolean
    C0001779 (UMLS CUI [1])
    cytopenia, bone marrow involvement
    Item
    patients with cytopenias caused by bone marrow involvement are eligible
    boolean
    C0010828 (UMLS CUI [1])
    C1517677 (UMLS CUI [2])
    informed consent
    Item
    all patients must give written informed consent prior to entering this study.
    boolean
    C0021430 (UMLS CUI [1])
    Item Group
    C0680251 (UMLS CUI)
    exclusion criteria
    Item
    you cannot participate in this study if any of the following apply to you:
    boolean
    C0680251 (UMLS CUI [1])
    unstable active infection on the basis of neutropenia
    Item
    unstable active infection on the basis of neutropenia
    boolean
    C0009450 (UMLS CUI [1,1])
    C0205177 (UMLS CUI [1,2])
    C0443343 (UMLS CUI [1,3])
    C0027947 (UMLS CUI [2])
    severe opportunistic infections
    Item
    previous severe opportunistic infections
    boolean
    C0029118 (UMLS CUI [1,1])
    C0205082 (UMLS CUI [1,2])
    severe immune mediated anemia or thrombocytopenia
    Item
    severe immune mediated anemia or thrombocytopenia
    boolean
    C0002880 (UMLS CUI [1,1])
    C0205082 (UMLS CUI [1,2])
    C0242584 (UMLS CUI [2,1])
    C0205082 (UMLS CUI [2,2])
    comorbidity
    Item
    serious underlying medical conditions
    boolean
    C0009488 (UMLS CUI [1])
    brain metastases or meningeal involvement
    Item
    brain metastases or meningeal involvement
    boolean
    C0220650 (UMLS CUI [1])
    C1704231 (UMLS CUI [2])
    other neoplasms
    Item
    history of other neoplasms
    boolean
    C0006826 (UMLS CUI [1,1])
    C0205394 (UMLS CUI [1,2])
    cardiac dysfunction
    Item
    significant underlying heart dysfunction
    boolean
    C3277906 (UMLS CUI [1])
    Pregnancy
    Item
    women who are pregnant or
    boolean
    C0032961 (UMLS CUI [1])
    eligibility criteria
    Item
    please note: there are additional inclusion/exclusion criteria. the study center will determine if you meet all of the criteria. if you do not qualify for the trial, study personnel will explain the reasons. if you do qualify, study personnel will explain the trial in detail and answer any questions you may have.
    boolean
    C1516637 (UMLS CUI [1])

    Use este formulário para feedback, perguntas e sugestões de aperfeiçoamento.

    Campos marcados com * são obrigatórios.

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial